U.S. Congressman Blaine Luetkemeyer recently published his thoughts on the need for a new, state-of-the-art research reactor at the University of Missouri — NextGen MURR.

Here’s an excerpt…

For so many of us, cancer isn’t just a word—it’s personal.  Whether it’s touched a friend, family member, or even ourselves, cancer has left its mark on our lives and our communities. It’s a fight that impacts not only our loved ones but also our entire nation. But here in the Third District, we are leading the charge in the fight against this devastating disease. With each passing day, research and treatment options are advancing, and I’m proud to say that Missouri is at the forefront of that progress.

Over the past 15 years, I’ve been an avid supporter of funding the nuclear reactor at the University of Missouri. This isn’t just about funding a reactor; it’s about powering life-saving discoveries. The NextGen MURR project will bring a new, 20-megawatt state-of-the-art research reactor to Mizzou, expanding critical medical isotope research and production for cancer treatments. These are the technologies that make a real difference in the lives of cancer patients—technologies that come from uranium, cobalt, and rare earth elements, which are the backbone of nuclear reactors and the radiopharmaceuticals they produce. NextGen MURR builds on the legacy of the existing MURR facility, the only U.S. producer of four essential medical isotopes used to treat liver, thyroid, pancreatic, and prostate cancers.  This new reactor will allow Missouri to remain a global leader in the development of radiopharmaceuticals, strengthening our role in research that will impact healthcare nationwide.